Literature DB >> 3404600

The association between genital ulcer disease and acquisition of HIV infection in homosexual men.

W E Stamm1, H H Handsfield, A M Rompalo, R L Ashley, P L Roberts, L Corey.   

Abstract

We analyzed the association of herpes simplex virus (HSV) infection and syphilis, the two most common causes of genital ulceration in homosexual men, with human immunodeficiency virus (HIV) infection in 200 men enrolled between 1983 and 1986 into a study evaluating the microbial causes of acute proctitis. Infection with HIV was independently associated with a history of syphilis, serologic evidence of syphilis, a history of HSV infection, and antibody to HSV-2. Antibody to HIV was not associated with a history of other genital infections or with antibody to Chlamydia trachomatis or HSV-1. Similar associations were observed in 111 asymptomatic homosexuals seen for HIV screening. Men who presented with primary HSV proctitis had a lower prevalence of HIV antibody than those with preexisting HSV-2 antibody (44% vs 68%); this suggests that HSV-2 infection antedated HIV infection. These data suggest that genital ulcerative diseases are an important risk factor for the acquisition of HIV infection in homosexual men; measures directed at control of these diseases may reduce the transmission of HIV in this population.

Entities:  

Mesh:

Year:  1988        PMID: 3404600

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  84 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake.

Authors:  S Koenig; Lc Ivers; S Pace; R Destine; F Leandre; R Grandpierre; J Mukherjee; Pe Farmer; Jw Pape
Journal:  HIV Ther       Date:  2010-03

Review 3.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Liver involvement in HIV-infected patients diagnosed with syphilis.

Authors:  N Jung; T Kümmerle; S D Brengelmann; J Gielen; C Lehmann; C Wyen; A Birtel; J Fischer; D Gillor; S Koch; J J Vehreschild; O A Cornely; G Fätkenheuer
Journal:  Infection       Date:  2012-04-25       Impact factor: 3.553

5.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

6.  Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis.

Authors:  A A Campagnari; R Karalus; M Apicella; W Melaugh; A J Lesse; B W Gibson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic.

Authors:  J L Meyer; R A Crosby; W L H Whittington; D Carrell; R Ashley-Morrow; A S Meier; R D Harrington; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

8.  Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.

Authors:  Gail F Shust; Sylvia Cho; Mimi Kim; Rebecca P Madan; Esmeralda M Guzman; Margaret Pollack; Julia Epstein; Hillel W Cohen; Marla J Keller; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2009-12-15       Impact factor: 3.886

9.  Laboratory diagnosis of syphilis with automated immunoassays.

Authors:  Antonella Marangoni; Alessandra Moroni; Silvia Accardo; Roberto Cevenini
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 10.  Behavioral and biomedical combination strategies for HIV prevention.

Authors:  Linda-Gail Bekker; Chris Beyrer; Thomas C Quinn
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.